TY - JOUR AU - Stavaux, Edouard AU - Goupil, François AU - Barreau, Guillaume AU - Septans, Anne Lise AU - Dautzenberg, Bertrand AU - Foulet-Rogé， Armelle AU - Padilla, Norbert AU - Urban, Thierry AU - Denis, Fabrice PY - 2022 DA - 2022/2/23 TI -使用智能手机自我评估应用程序进行烟草诱发疾病(COPD，心血管疾病，癌症)筛查策略并鼓励戒烟:观察性研究JO - JMIR公共卫生监测SP - e19877 VL - 8 IS - 2kw -戒烟KW -移动健康KW -自我评估，肺癌KW -早期发现KW -烟草引起的病理AB -背景:通过移动应用程序进行患者自我评估可以发现可采取行动的症状，并已被证明可以早期发现肺癌复发，从而延长生存期。目的:本研究的目的是通过一款自我评估智能手机应用程序，评估当前和已戒烟者中与烟草诱导的主要病理相关的主要症状的发生率，并评估该应用程序鼓励用户戒烟或减少消费的能力，以及其在诊断时对早期肺癌阶段的影响。方法:通过在法国萨特县开展的一项广告活动，招募了当前吸烟者和已戒烟者，该广告活动建议免费下载一款智能手机应用程序。应用程序用户被要求回答与烟草诱发疾病(慢性阻塞性肺病、心血管疾病、癌症)相关症状相关的13个问题。如果有任何肯定的答案，就会显示一条建议用户咨询医生的消息。此外，他们还被问及在回答这13个问题之前和之后的戒烟意愿。最后，通过将不同来源的数据与前一年同期的数据进行比较，评估了在我们的应用程序发布期间诊断的1期或2期肺癌的发病率。结果:在符合评估条件的5671名使用者中，大多数人(418 /5671,72.6%)收到了警示，而当前吸烟者的发生率更高(2833/3679,77.0% vs 1298/1992, 65.2%;P <措施)。触发通知的最常见症状是疲劳(2023/5671,35.7%)、咳嗽(1658/5671,29.2%)、呼吸困难(1502/5671,26.5%)和持续胸痛(1286/5671,22.7%)。 Of the current smokers, 14.0% (515/3679) showed symptoms suggesting COPD, 15.5% (571/3679) showed symptoms suggesting stable angina, 12.4% (455/3679) probably had lower extremity artery disease, and 6.8% (249/3679) had possible cancer. Of the users, 36.5% (1343/3679) claimed that they thought about quitting smoking, and 48.7% (1795/3679) had thought about reducing their consumption. Surgery-eligible stage 1 and 2 lung cancer incidence was 24% (14/58) during the study period versus 9% (5/54) during the previous year in Sarthe county (P=.04), whereas it remained unchanged in the neighboring county of Maine-et-Loire. Conclusions: A majority of current and ex-smokers showed worrying symptoms, and the use of a self-assessment smartphone app may drive a majority of smokers toward the intention of smoking cessation or decreasing consumption. A randomized study should be performed to confirm this intention and to support the potential increase of symptomatic lung cancer detection at early, surgery-accessible stages. Trial Registration: ClinicalTrials.gov NCT04048954; https://www.clinicaltrials.gov/ct2/show/NCT04048954 SN - 2369-2960 UR - https://publichealth.www.mybigtv.com/2022/2/e19877 UR - https://doi.org/10.2196/19877 UR - http://www.ncbi.nlm.nih.gov/pubmed/35195530 DO - 10.2196/19877 ID - info:doi/10.2196/19877 ER -